Status:

RECRUITING

Body Composition Assessment and Monitoring in Inflammatory Bowel Disease

Lead Sponsor:

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Collaborating Sponsors:

Grupo Español de trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU)

Conditions:

Body Composition Changes

Malnutrition

Eligibility:

All Genders

18-64 years

Brief Summary

This is a single-center, prospective observational study aiming to describe changes in body composition (specifically, percentage of lean mass and phase angle) in patients with active inflammatory bow...

Eligibility Criteria

Inclusion

  • Any sex.
  • Age between 18 and 64 years.
  • Patients with a definitive diagnosis (\>3 months) of Crohn's disease or ulcerative colitis, according to European Crohn's and Colitis Organization criteria.
  • Moderate-to-severe disease luminal activity, with an indication for biologic or JAKi therapy for the induction of clinical remission.

Exclusion

  • Unclassified IBD.
  • History of intestinal resection for IBD, with the exception of ileocecal resection.
  • Short bowel syndrome.
  • Indication for medical treatment due to postsurgical recurrence.
  • Active perianal disease.
  • Indication for medical treatment due to intestinal stricture.
  • Previous participation in a clinical trial involving medication for IBD treatment.
  • Engaging in vigorous physical activity (\>6 Metabolic Equivalent of Task, METs) for more than 3 days per week.
  • Habitual alcohol consumption (\>1 standard drink unit/day).
  • Diabetes mellitus with inadequate glycemic control.
  • Chronic use of diuretics.
  • Chronic kidney disease on dialysis.
  • Presence of dependent edema and/or ascites.
  • Cardiac pacemaker bearers.
  • Pregnant or lactating women.
  • Inability to sign informed consent.

Key Trial Info

Start Date :

July 15 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

July 15 2028

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT07162701

Start Date

July 15 2025

End Date

July 15 2028

Last Update

September 9 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Unidad de Enfermedad Inflamatoria Intestinal

Barcelona, Spain, 08025